DNA ploidy heterogeneity in endometrial carcinoma: Comparison between curettage and hysterectomy specimens

International Journal of Gynecological Pathology

Volumn 29, Issue 6, 2010, Pages 572-578

  Pradhan, Manohar ^b   Abeler, Vera Maria ^b   Davidson, Ben ^b,c   Kildal, Wanja ^a   Nybøen, Åsmund ^a   Tropé, Claes Göran ^a   Risberg, Björn ^a,b   Danielsen, Håvard Emil ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Department of Pathology ^*  (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Curettage; DNA ploidy; Endometrial carcinoma; Hysterectomy

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CURETTAGE; DIPLOIDY; ENDOMETRIUM CARCINOMA; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; TISSUE SECTION; TUMOR DIFFERENTIATION;

EID: 78149282748     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181e2e8ee     Document Type: Article

References (27)

1. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007:3. Available from: www.cancer.org/downloads/STT/Global-Cancer- Facts-and-Figures-2007-rev.pdf Accessed January 14, 2010.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Nordstrom B, Strang P, Lindgren A, et al. Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol 1996;15:191-201.
4. Lampe B, Kurzl R, Hantschmann P. Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage. Int J Gynecol Pathol 1995;14:2-6.
5. Oakley G, Nahhas WA. Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue. Eur J Gynecol Oncol 1989;10:255-60.
6. Vorgias G, Lekka J, Katsoulis M, et al. Diagnostic accuracy of prehysterectomy curettage in determining tumor type and grade in patients with endometrial cancer. Med Gen Med 2003;5:7.
7. Lundgren C, Auer G, Frankendal B, et al. Prognostic factors in surgical stage I endometrial carcinoma. Acta Oncol 2004;43: 49-56.
8. Zaino RJ, Davis AT, Ohlsson-Wilhelm BM, et al. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study. Int J Gynecol Pathol 1998;17:312-9.
9. Susini T, Amunni G, Molino C, et al. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called "low-risk" patients with well and moderately differentiated tumors. Cancer 2007;109:882-90.
10. Wik E, Trovik J, Iversen OE, et al. Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. Am J Obstet Gynecol 2009;201:603-7.
11. Salvesen HB, Akslen LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002;110:673-89.
12. Hogberg T, Fredstorp-Lidebring M, Alm P, et al. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer 2004;14:437-50.
13. Mangili G, Montoli S, De MP, et al. The role of DNA ploidy in postoperative management of stage I endometrial cancer. Ann Oncol 2008;19:1278-83.
14. Mariani A, Sebo TJ, Webb MJ, et al. Molecular and histo-pathologic predictors of distant failure in endometrial cancer. Cancer Detect Prev 2003;27:434-41.
15. Terada K, Mattson D, Goo D, et al. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer. Gynecol Oncol 2004;95:483-7.
16. Podratz KC, Wilson TO, Gaffey TA, et al. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endo-metrial cancer patients. Am J Obstet Gynecol 1993;168:1206-13.
17. Stendahl U, Strang P, Wagenius G, et al. Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 1991;10:271-84.
18. Baak JP, Snijders W, van Diermen B, et al. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol 2003;21:4214-21.
19. Susini T, Rapi S, Massi D, et al. Preoperative evaluation of tumor ploidy in endometrial carcinoma: an accurate tool to identify patients at risk for extrauterine disease and recurrence. Cancer 1999;86:1005-12.
20. Silverberg SG, Kurman RJ, Nogales F, et al. Tumours of uterine corpus. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:218-32.
21. Pradhan M, Abeler VM, Danielsen HE, et al. Image cytometry DNA ploidy correlates with histological subtypes in endome-trial carcinomas. Mod Pathol 2006;19:1227-35.
22. Rosenberg P, Wingren S, Guerrieri C. Flow cytometric DNA-heterogeneity in paraffin-embedded endometrial cancer. Acta Oncol 1997;36:23-6.
23. Iversen OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986;155:770-6.
24. Lindahl B, Alm P, Killander D, et al. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations. Anticancer Res 1987; 7:781-9.
25. Atkin NB. Frequency of hyperdiploid chromosome complements in endometrioid tumors of the endometrium whereas similar tumors in the ovary tend to show hypodiploidy: a significant difference that may not be distinguishable by flow cytometry of DNA content. Cytogenet Genome Res 2002;97:39-42.
26. Horree N, van Diest PJ, Sie-Go DM, et al. The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators. Hum Pathol 2007;38:1232-8.
27. Kurokawa H, Zhang M, Matsumoto S, et al. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 2005;34:602-7.